Exogen Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 66
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $61.4M
Latest Deal Amount

Exogen General Information


Developer of medical devices for the non-invasive treatment of bone injury and disease. The company focuses on the biophysical modulation and treatment of musculoskeletal injuries and disease.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
  • P.O. Box 6860
  • Piscataway Township, NJ 08855
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Sep-1999 $61.4M 000.00 000.00 Completed Generating Revenue
3. PIPE 21-Oct-1997 00.00 000.00 Completed Generating Revenue
2. IPO 18-Jul-1995 $30M $30M Completed Generating Revenue
1. Early Stage VC Completed
To view Exogen’s complete valuation and funding history, request access »

Exogen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exogen Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Delphi Ventures Venture Capital Minority 000 0000 000000 0
SightLine Partners Growth/Expansion Minority 000 0000 000000 0
To view Exogen’s complete investors history, request access »

Exogen Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 01-Mar-1993 000000000 00000 00 Buildings and Property
To view Exogen’s complete investments history, request access »